AI-Based Quality Control for Radiology Reporting
Effect of an AI-Based Radiology Report Quality-Control System on Report Accuracy and Workflow Efficiency: A Radiologist-Level Randomized Controlled Trial
1 other identifier
interventional
109
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn whether an artificial intelligence (AI)-based radiology report quality-control system can improve the accuracy and workflow efficiency of routine radiology reporting among active radiologists at Tongji Hospital. The main questions it aims to answer are:
- Does access to the AI quality-control system reduce quality problems remaining in final radiology reports?
- Does access to the AI quality-control system improve reporting and reviewing efficiency?
- In the two-stage reporting workflow, do the effects of AI differ depending on whether AI is available to the reporting radiologist, the reviewing radiologist, or both? Researchers will compare radiologists assigned to receive access to Radiology Report GPT with radiologists who continue the usual reporting workflow without access to the study AI system. Radiologists are randomized at the individual level. Because CT and MR reports commonly involve both a reporting radiologist and a reviewing radiologist, report-level analyses will classify reports according to AI availability at the two workflow stages, resulting in four combinations of reporter and reviewer AI exposure. The primary randomized evaluation will cover the first month after intervention initiation, with prespecified secondary and exploratory analyses extending through 3 months. Participants will:
- Be assigned to either the AI quality-control group or the usual-workflow control group.
- Continue their routine radiology reporting and reviewing work during the study period.
- If assigned to the AI group, receive access to Radiology Report GPT, which automatically pre-reviews submitted radiology reports and provides quality-control alerts and suggested revisions. Radiologists will retain final decision authority over all reports. Final-report accuracy will be assessed independently of the intervention AI system and will include human review. Additional prespecified outcomes will examine report revisions, AI interaction measures, stage-specific and cross-stage workflow effects, recommended imaging follow-up and other downstream health-care utilization, patient satisfaction, and referring-clinician satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2026
CompletedFirst Submitted
Initial submission to the registry
October 3, 2026
CompletedFirst Posted
Study publicly available on registry
October 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
October 13, 2026
October 1, 2026
1 month
October 3, 2026
October 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Presence of at Least One Confirmed Residual Quality-Control Problem in the Final Radiology Report
For each eligible final radiology report, this binary outcome indicates whether at least one confirmed prespecified residual quality-control problem is present (yes/no). The outcome-assessment process will be independent of the intervention AI system and will include human review. Prespecified categories include textual/terminology errors, sex or examination-type inconsistencies, formatting/numerical errors, findings-impression inconsistencies, lesion location/count discrepancies, omissions, and missing or incorrect diagnostic classifications.
During the first month after intervention initiation
Radiology Report Turnaround Time
Turnaround time will be measured for each eligible radiology report as the elapsed time, from completion of the imaging examination to final report approval. Both timestamps will be obtained from the hospital information systems. Lower values indicate faster completion of the radiology reporting workflow.
During the first month after intervention initiation
Secondary Outcomes (2)
Inter-Report Interval
During the first month after intervention initiation
Inter-Check Interval
During the first month after intervention initiation
Other Outcomes (3)
Patient Adherence
During the 3-month secondary evaluation period
Patient Satisfaction
During the 3-month secondary evaluation period
Referring-Clinician Satisfaction
During the 3-month secondary evaluation period
Study Arms (2)
AI Quality-Control Group
EXPERIMENTALRadiologists enrolled in this arm receive access to the study AI radiology report quality-control system within the routine reporting workflow. After report submission, the system performs automated pre-review and may present alerts and suggested revisions. Radiologists retain final decision authority.
Usual Workflow Control Group
NO INTERVENTIONRadiologists enrolled in this arm continue the existing RIS reporting and reviewing workflow without access to the study AI quality-control alerts or suggested revisions.
Interventions
Radiology Report GPT is an AI-based pre-review and quality-control system for radiology reports. After a report is submitted, the system may identify potential textual/terminology errors, patient-sex inconsistencies, formatting or numerical errors, examination-type inconsistencies, findings-impression inconsistencies, lesion location/count discrepancies, omissions between findings and impression, and missing or incorrect diagnostic classifications. When a potential issue is detected, the system presents an alert and suggested revision. The radiologist remains responsible for the final report and may accept, modify, or ignore the suggestion. The system does not automatically edit or sign the report. The exact software/model version and the trial deployment mode will be locked and documented before intervention activation.
Eligibility Criteria
You may qualify if:
- Radiologist working in the Department of Radiology at Tongji Hospital.
- Participated in routine radiology reporting during the pre-intervention reference period.
- Reporting work includes at least one target imaging examination type/workflow covered by the study AI quality-control system (CT, MR, and/or CR as applicable).
- Has a valid physician identifier that permits linkage of radiology reports, workflow timestamps, and randomized study assignment.
- Able and willing to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 3, 2026
First Posted
October 8, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
October 13, 2026
Record last verified: 2026-10